CLINICAL_TRIALS
trial_result
· 2017-05-04
Clinical Trial Update: Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris [Phase 1]
Summary
This Phase 1 trial compared Adapalene Gel 0.3% to the Differin brand and to placebo for acne vulgaris. The study has completed and assessed safety and prelimina…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED